Skip to main content
BioMed Research International logoLink to BioMed Research International
. 2021 Mar 19;2021:3702061. doi: 10.1155/2021/3702061

Retracted: MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer through Targeting CAB39

BioMed Research International 1,
PMCID: PMC8019383  PMID: 33855067

BioMed Research International has retracted the article titled “MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer through Targeting CAB39 [1]” due to an error in sequence targeting.

It was raised to our attention [2] that both the anti-miR oligonucleotides, UUCUCCGAACGUGUCACGUTT and ACGUGACACGUUCGGAGAATT, have no clear target and have been used in many other articles as non-targeting controls. The sequences for si-CAB39, miR-NC, anti-miR-NC, and si-NC were not given in the article. The authors could not be contacted.

References

  • 1.Guo R., Jianhua G., Zhang Z., Wang Y., Chuan G. MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer through Targeting CAB39. BioMed Research International. 2017;2017:11. doi: 10.1155/2017/2381482.2381482 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 2.Labbé C., Grima N., Gautier T., Favier B., Byrne J. A. Semi-automated fact-checking of nucleotide sequence reagents in biomedical research publications: The Seek & Blastn tool. PLoS One. 2019;14(3, article e0213266) doi: 10.1371/journal.pone.0213266. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BioMed Research International are provided here courtesy of Wiley

RESOURCES